Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000875689 | SCV001018149 | likely benign | Actin accumulation myopathy | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003413700 | SCV004126072 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | ACTA1: BP4, BP7 |
Prevention |
RCV004754597 | SCV005362336 | uncertain significance | ACTA1-related disorder | 2024-09-10 | no assertion criteria provided | clinical testing | The ACTA1 c.324C>A variant is not predicted to result in an amino acid change (p.=). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.022% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |